76 related articles for article (PubMed ID: 19931460)
1. Nanomolar affinity, iminosugar-based chemical probes for specific labeling of lysosomal glucocerebrosidase.
van Scherpenzeel M; van den Berg RJ; Donker-Koopman WE; Liskamp RM; Aerts JM; Overkleeft HS; Pieters RJ
Bioorg Med Chem; 2010 Jan; 18(1):267-73. PubMed ID: 19931460
[TBL] [Abstract][Full Text] [Related]
2. Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients.
Chang HH; Asano N; Ishii S; Ichikawa Y; Fan JQ
FEBS J; 2006 Sep; 273(17):4082-92. PubMed ID: 16934036
[TBL] [Abstract][Full Text] [Related]
3. Chaperone activity of bicyclic nojirimycin analogues for Gaucher mutations in comparison with N-(n-nonyl)deoxynojirimycin.
Luan Z; Higaki K; Aguilar-Moncayo M; Ninomiya H; Ohno K; García-Moreno MI; Ortiz Mellet C; García Fernández JM; Suzuki Y
Chembiochem; 2009 Nov; 10(17):2780-92. PubMed ID: 19830760
[TBL] [Abstract][Full Text] [Related]
4. Rapid modifications of N-substitution in iminosugars: development of new β-glucocerebrosidase inhibitors and pharmacological chaperones for Gaucher disease.
Cheng WC; Weng CY; Yun WY; Chang SY; Lin YC; Tsai FJ; Huang FY; Chen YR
Bioorg Med Chem; 2013 Sep; 21(17):5021-8. PubMed ID: 23880081
[TBL] [Abstract][Full Text] [Related]
5. Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles.
Sawkar AR; Adamski-Werner SL; Cheng WC; Wong CH; Beutler E; Zimmer KP; Kelly JW
Chem Biol; 2005 Nov; 12(11):1235-44. PubMed ID: 16298303
[TBL] [Abstract][Full Text] [Related]
6. The subcellular localization of soluble and membrane-bound lysosomal enzymes in I-cell fibroblasts: a comparative immunocytochemical study.
van Dongen JM; Willemsen R; Ginns EI; Sips HJ; Tager JM; Barranger JA; Reuser AJ
Eur J Cell Biol; 1985 Nov; 39(1):179-89. PubMed ID: 2935398
[TBL] [Abstract][Full Text] [Related]
7. Iminosugar-based galactoside mimics as inhibitors of galactocerebrosidase: SAR studies and comparison with other lysosomal galactosidases.
Biela-Banaś A; Oulaïdi F; Front S; Gallienne E; Ikeda-Obatake K; Asano N; Wenger DA; Martin OR
ChemMedChem; 2014 Dec; 9(12):2647-52. PubMed ID: 25377381
[TBL] [Abstract][Full Text] [Related]
8. A systematic investigation of iminosugar click clusters as pharmacological chaperones for the treatment of Gaucher disease.
Joosten A; Decroocq C; de Sousa J; Schneider JP; Etamé E; Bodlenner A; Butters TD; Compain P
Chembiochem; 2014 Jan; 15(2):309-19. PubMed ID: 24375964
[TBL] [Abstract][Full Text] [Related]
9.
Wolfsgruber A; Thonhofer M; Weber P; Nasseri SA; Fischer R; Schalli M; Stütz AE; Withers SG; Wrodnigg TM
Molecules; 2020 Oct; 25(20):. PubMed ID: 33050585
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of new thiodigalactoside-based chemical probes to label galectin-3.
van Scherpenzeel M; Moret EE; Ballell L; Liskamp RM; Nilsson UJ; Leffler H; Pieters RJ
Chembiochem; 2009 Jul; 10(10):1724-33. PubMed ID: 19492387
[TBL] [Abstract][Full Text] [Related]
11. LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase.
Reczek D; Schwake M; Schröder J; Hughes H; Blanz J; Jin X; Brondyk W; Van Patten S; Edmunds T; Saftig P
Cell; 2007 Nov; 131(4):770-83. PubMed ID: 18022370
[TBL] [Abstract][Full Text] [Related]
12. Selective Targeting of the Interconversion between Glucosylceramide and Ceramide by Scaffold Tailoring of Iminosugar Inhibitors.
Baudoin-Dehoux C; Castellan T; Rodriguez F; Rives A; Stauffert F; Garcia V; Levade T; Compain P; Génisson Y
Molecules; 2019 Jan; 24(2):. PubMed ID: 30669468
[TBL] [Abstract][Full Text] [Related]
13. Mass spectrometric study of gas-phase ions of acid β-glucosidase (Cerezyme) and iminosugar pharmacological chaperones.
Rajabi K
J Mass Spectrom; 2014 Oct; 49(10):1002-9. PubMed ID: 25303390
[TBL] [Abstract][Full Text] [Related]
14. Miglustat (NB-DNJ) works as a chaperone for mutated acid beta-glucosidase in cells transfected with several Gaucher disease mutations.
Alfonso P; Pampín S; Estrada J; Rodríguez-Rey JC; Giraldo P; Sancho J; Pocoví M
Blood Cells Mol Dis; 2005; 35(2):268-76. PubMed ID: 16039881
[TBL] [Abstract][Full Text] [Related]
15. Binding parameters and thermodynamics of the interaction of imino sugars with a recombinant human acid alpha-glucosidase (alglucosidase alfa): insight into the complex formation mechanism.
Yoshimizu M; Tajima Y; Matsuzawa F; Aikawa S; Iwamoto K; Kobayashi T; Edmunds T; Fujishima K; Tsuji D; Itoh K; Ikekita M; Kawashima I; Sugawara K; Ohyanagi N; Suzuki T; Togawa T; Ohno K; Sakuraba H
Clin Chim Acta; 2008 May; 391(1-2):68-73. PubMed ID: 18328816
[TBL] [Abstract][Full Text] [Related]
16. [Study of the specificity of human lysosomal glycolipid hydrolases using synthetic fluorogenic substrates].
Vidershaĭn GIa; Kozlova IK; Il'ina GS; Mikhaĭlova MA
Bioorg Khim; 1988 Aug; 14(8):1014-26. PubMed ID: 3146253
[TBL] [Abstract][Full Text] [Related]
17. Fluorescent-tagged sp2-iminosugars with potent β-glucosidase inhibitory activity.
Aguilar-Moncayo M; García-Moreno MI; Stütz AE; García Fernández JM; Wrodnigg TM; Ortiz Mellet C
Bioorg Med Chem; 2010 Nov; 18(21):7439-45. PubMed ID: 20889348
[TBL] [Abstract][Full Text] [Related]
18. Measurement of lysosomal glucocerebrosidase activity in mouse liver using a fluorescence-activated cell sorter assay.
Chan KW; Waire J; Simons B; Karey K; Fung J; Copeland D; Andrews L
Anal Biochem; 2004 Nov; 334(2):227-33. PubMed ID: 15494128
[TBL] [Abstract][Full Text] [Related]
19. In vitro inhibition of glycogen-degrading enzymes and glycosidases by six-membered sugar mimics and their evaluation in cell cultures.
Kuriyama C; Kamiyama O; Ikeda K; Sanae F; Kato A; Adachi I; Imahori T; Takahata H; Okamoto T; Asano N
Bioorg Med Chem; 2008 Aug; 16(15):7330-6. PubMed ID: 18595718
[TBL] [Abstract][Full Text] [Related]
20. Promising results of the chaperone effect caused by imino sugars and aminocyclitol derivatives on mutant glucocerebrosidases causing Gaucher disease.
Sánchez-Ollé G; Duque J; Egido-Gabás M; Casas J; Lluch M; Chabás A; Grinberg D; Vilageliu L
Blood Cells Mol Dis; 2009; 42(2):159-66. PubMed ID: 19167250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
